Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Pharmacology in Addiction Treatment
NCT00000239Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000239.